Literature DB >> 16673097

Toxic osteoblastoma of the scapula.

T Theologis1, S Ostlere, C L M H Gibbons, N A Athanasou.   

Abstract

Osteoblastoma rarely occurs in the scapula, and toxic osteoblastoma is a very rare subtype of this bone-forming tumour. This report details the clinical, radiological and pathological features of a toxic osteoblastoma of the scapula; it is the first reported case to be diagnosed correctly pre-operatively and treated appropriately by excision.

Entities:  

Mesh：

Year:  2006        PMID： 16673097     DOI： 10.1007/s00256-006-0140-2

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN： 0364-2348            Impact factor:   2.199


  5 in total

1.  Osteoblastoma of the scapula; a case report.

Authors:  A J SCHEIN
Journal:  J Bone Joint Surg Am       Date:  1959-03       Impact factor: 5.284

2.  Severe toxic osteoblastoma of the humerus associated with diffuse periostitis of multiple bones.

Authors:  S Dale; W H Breidahl; D Baker; P D Robbins; M Sundaram
Journal:  Skeletal Radiol       Date:  2001-08       Impact factor: 2.199

3.  A case of osteoblastoma associated with severe systemic toxicity.

Authors:  J M Mirra; K Cove; E Theros; R Paladugu; J Smasson
Journal:  Am J Surg Pathol       Date:  1979-10       Impact factor: 6.394

4.  Bone tumors of the coracoid process of the scapula.

Authors:  A Ogose; F H Sim; M I O'Connor; K K Unni
Journal:  Clin Orthop Relat Res       Date:  1999-01       Impact factor: 4.176

5.  Aggressive osteoblastoma.

Authors:  P A Revell; C L Scholtz
Journal:  J Pathol       Date:  1979-04       Impact factor: 7.996
  5 in total
  2 in total

Review 1.  Elevated β-hCG associated with aggressive Osteoblastoma.

Authors:  Carol D Morris; Meera R Hameed; Narasimhan P Agaram; Sinchun Hwang
Journal:  Skeletal Radiol       Date:  2017-04-10       Impact factor: 2.199

Review 2.  Benign Bone Tumors: An Overview of What We Know Today.

Authors:  Sara De Salvo; Vito Pavone; Sebastiano Coco; Eleonora Dell'Agli; Chiara Blatti; Gianluca Testa
Journal:  J Clin Med       Date:  2022-01-28       Impact factor: 4.241
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.